FOS and neoplasm: We found that upon LLC development, enhanced levels of fragments encoding tumour-specific genes Hmga2, Fos, Myc and Jun were detected in the blood of tumour-bearing mice, and after DNase I treatment levels of all fragments except for Fos-specific ones were reduced.